Episode Details

This episode explores the strategic evolution of a pharmaceutical group as it transitions into an innovation-focused global player. By revitalising growth drivers through a refined research model, China Medical System is successfully navigating industry shifts and optimizing its product portfolio. We delve into how a commitment to unmet medical needs and a robust international footprint are paving the way for a sustainable growth trajectory.

• Breakthrough therapies reaching the market and the diverse pipeline of innovative drugs currently under regulatory review

• How a hub-based international strategy is accelerating expansion into emerging markets

• The rise of specialized divisions dedicated to skin health and ophthalmology